NeuBase Therapeutics Buy Hold or Sell Recommendation
| NBSEDelisted Stock | USD 1.62 0.17 9.50% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding NeuBase Therapeutics is 'Not Rated'. Macroaxis provides NeuBase Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NBSE positions.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Note, we conduct extensive research on individual companies such as NeuBase and provide practical buy, sell, or hold advice based on investors' constraints. NeuBase Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
NeuBase |
Execute NeuBase Therapeutics Buy or Sell Advice
The NeuBase recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NeuBase Therapeutics. Macroaxis does not own or have any residual interests in NeuBase Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NeuBase Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
NeuBase Therapeutics Trading Alerts and Improvement Suggestions
| NeuBase Therapeutics is not yet fully synchronised with the market data | |
| NeuBase Therapeutics may become a speculative penny stock | |
| NeuBase Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (33.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NeuBase Therapeutics currently holds about 29.85 M in cash with (29.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93. | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders |
NeuBase Therapeutics Returns Distribution Density
The distribution of NeuBase Therapeutics' historical returns is an attempt to chart the uncertainty of NeuBase Therapeutics' future price movements. The chart of the probability distribution of NeuBase Therapeutics daily returns describes the distribution of returns around its average expected value. We use NeuBase Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NeuBase Therapeutics returns is essential to provide solid investment advice for NeuBase Therapeutics.
| Mean Return | -1.02 | Value At Risk | -11.84 | Potential Upside | 8.42 | Standard Deviation | 6.12 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NeuBase Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Insider Trading [view details]
NeuBase Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NeuBase . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About NeuBase Therapeutics Buy or Sell Advice
When is the right time to buy or sell NeuBase Therapeutics? Buying financial instruments such as NeuBase Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NeuBase Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Dividend Yield ETFs Thematic Idea Now
High Dividend Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Dividend Yield ETFs theme has 107 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Dividend Yield ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in NeuBase Stock
If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |